menu
    • menu

    Company profile for Eisai

    NEW Drugs in Dev: 71
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Eisai Co Ltd. is a pharmaceutical company that discovers, develops, manufactures, and markets pharmaceuticals, including prescription medicines, OTC drugs, and generics. The company’s franchise areas in research include neurology and oncology. Eisai’s major products include Pariet/AcipHex, a proton pump inhibitor; Aricept, an anti-Alzheimer agent; perampanel, Halaven, an anti-cancer agent; Fycompa tablets for the treatment...
    Eisai Co Ltd. is a pharmaceutical company that discovers, develops, manufactures, and markets pharmaceuticals, including prescription medicines, OTC drugs, and generics. The company’s franchise areas in research include neurology and oncology. Eisai’s major products include Pariet/AcipHex, a proton pump inhibitor; Aricept, an anti-Alzheimer agent; perampanel, Halaven, an anti-cancer agent; Fycompa tablets for the treatment of epilepsy and peripheral neuropathy. Eisai has production plants in Japan, the UK, China, and India and laboratories in Japan, the US, and the UK; operations in the Americas, Asia, Latin America, EMEA, and Oceania.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Eisaijapan Flag
    Country
    Country
    Japan
    Address
    Address
    4-6-10 Koishikawa, Bunkyo-ku, Tokyo 112-8088
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.eisai.com/index.html
    Linkedin
    Linkedin
    https://www.linkedin.com/company/eisaiglobal/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/Eisai_SDGs

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    China Adds LEQEMBI to National Drug Reimbursement List
    China Adds LEQEMBI to National Drug Reimbursement List

    08 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/08/3202014/0/en/LEQEMBI-lecanemab-for-the-Treatment-of-Early-Alzheimer-s-Disease-Included-in-China-s-Commercial-Insurance-Innovative-Drug-List.html

    GLOBENEWSWIRE
    08 Dec 2025
    Share Share
    Merck, Eisai End Keytruda-Lenvima Collaboration In Liver Cancer
    Merck, Eisai End Keytruda-Lenvima Collaboration In Liver Cancer

    29 Oct 2025

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/merck-eisai-scrap-ambitions-keytruda-lenvima-pairing-liver-cancer-subtype-after-survival

    FIERCE PHARMA
    29 Oct 2025
    Share Share
    Eisai’s Leqembi Approved in Canada
    Eisai’s Leqembi Approved in Canada

    24 Oct 2025

    // HEALTH CANADA

    https://pdf.hres.ca/dpd_pm/00082171.PDF

    HEALTH CANADA
    24 Oct 2025
    Share Share
    Keytruda and Lenvima Show Long-Term Survival Benefit
    Keytruda and Lenvima Show Long-Term Survival Benefit

    18 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251018972232/en/KEYTRUDA-pembrolizumab-Plus-LENVIMA-lenvatinib-Demonstrates-Durable-5-Year-Survival-Benefit-Versus-Chemotherapy-for-Patients-With-Advanced-Endometrial-Carcinoma-Following-One-Prior-Platinum-Based-Regimen

    BUSINESSWIRE
    18 Oct 2025
    Share Share
    TIME Selects Leqembi-Iqlik As Top Innovation Of 2025
    TIME Selects Leqembi-Iqlik As Top Innovation Of 2025

    14 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/leqembi-iqlik-lecanemab-irmb-selected-by-time-as-one-of-the-best-innovations-of-2025-302582917.html

    PR NEWSWIRE
    14 Oct 2025
    Share Share
    First Patient Treated With Leqembi® (Lecanemab) In The Nordics
    First Patient Treated With Leqembi® (Lecanemab) In The Nordics

    14 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/first-patient-treated-with-leqembi-lecanemab-in-the-nordics-302583111.html

    PR NEWSWIRE
    14 Oct 2025
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Eisai and get a quotation

    Eisai is a supplier offers 18 products (APIs, Excipients or Intermediates).

    Find Azilsartan Medoxomil Potassium bulk with JDMF offered by Eisai

    Find Donepezil bulk with JDMF offered by Eisai

    Find Epalrestat bulk with JDMF offered by Eisai

    Find Eribulin bulk with JDMF offered by Eisai

    Find Fosravuconazole bulk with JDMF offered by Eisai

    Find Pranlukast Hydrate bulk with JDMF offered by Eisai

    Find Rabeprazole Sodium bulk with JDMF offered by Eisai

    Find Ramelteon bulk with JDMF offered by Eisai

    Find Teprenone bulk with JDMF offered by Eisai

    Find Bentiromide bulk offered by Eisai

    Find Eperisone bulk offered by Eisai

    Find Menfegol bulk offered by Eisai

    Find Donepezil bulk offered by Eisai

    Find Eribulin bulk offered by Eisai

    Find Lenvatinib Mesylate bulk offered by Eisai

    Find Perampanel bulk offered by Eisai

    Find Rabeprazole Sodium bulk offered by Eisai

    Find Teprenone bulk offered by Eisai

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search